SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000909661-00-000027
Filing Date
2000-04-04
Accepted
2000-04-04 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE BOILINIFARALLON CAPITAL (CP) INVESTORS, L.P.FARALLON CAPITAL INSTITUTIONAL PARNTERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARNTERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARNTERS, L.P.FARALLON CAPITAL MANAGEMENT LL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 TO SCHEDULE 13D SC 13D/A 94307
  Complete submission text file 0000909661-00-000027.txt   97041
Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279

Mailing Address 1454 PAGE MILL RD PALO ALTO CA 94304
Business Address 1454 PAGE MILL RD PALO ALTO CA 94304 6504945600
CRESCENDO PHARMACEUTICALS CORP (Subject) CIK: 0001042138 (see all company filings)

IRS No.: 770460388 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51643 | Film No.: 593624
SIC: 2834 Pharmaceutical Preparations